TradingKey

mehr Informationen über Procept Biorobotics Corp Unternehmen

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Unternehmensinformationen

BörsenkürzelPRCT

Name des UnternehmensProcept Biorobotics Corp

IPO-datumSep 15, 2021

CEOMr. Larry L. Wood

Anzahl der mitarbeiter756

WertpapierartOrdinary Share

GeschäftsjahresendeSep 15

Addresse150 Baytech Drive

StadtSAN JOSE

BörseNASDAQ Global Market Consolidated

LandUnited States of America

Postleitzahl95134

Telefon16502329832

Websitehttps://www.procept-biorobotics.com/

BörsenkürzelPRCT

IPO-datumSep 15, 2021

CEOMr. Larry L. Wood

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

863.16K

+2.37%

Mr. Larry L. Wood

President, Chief Executive Officer, Director

188.36K

+3056.17%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

Ms. Elisabeth Little

Independent Director

11.02K

--

Thomas M. Prescott

Independent Chairman of the Board

3.90K

+65.22%

Ms. Alaleh Azarkhish Nouri

Executive Vice President, Chief Legal Officer, Corporate Secretary

--

Ms. Amy M. Dodrill

Independent Director

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Frederic H. (Fred) Moll, M.D.

Independent Director

863.16K

+2.37%

Mr. Larry L. Wood

President, Chief Executive Officer, Director

188.36K

+3056.17%

Mr. Taylor C. Harris

Independent Director

134.25K

+1.16%

Mr. Kevin Waters

Executive Vice President, Chief Financial Officer

66.61K

-6.22%

Mr. Hisham Shiblaq

Executive Vice President, Chief Commercial Officer

18.05K

--

Ms. Mary Garrett

Independent Director

14.38K

+11.97%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

Nach RegionUSD

Name

Umsatz

Anteil

United States

60.29M

87.18%

Outside United States

8.87M

12.82%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Hand pieces and other consumables

42.49M

61.43%

System sales and rentals

22.54M

32.59%

Service

4.13M

5.98%

Aktionärsstatistik

Aktualisiert: Thu, Aug 14

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Fidelity Management & Research Company LLC

13.85%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

6.70%

AllianceBernstein L.P.

3.88%

Westfield Capital Management Company, L.P.

2.87%

Andere

63.29%

Aktionäre

Anteil

Fidelity Management & Research Company LLC

13.85%

The Vanguard Group, Inc.

9.41%

BlackRock Institutional Trust Company, N.A.

6.70%

AllianceBernstein L.P.

3.88%

Westfield Capital Management Company, L.P.

2.87%

Andere

63.29%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

59.68%

Investment Advisor/Hedge Fund

28.08%

Individual Investor

4.45%

Hedge Fund

3.53%

Research Firm

3.48%

Bank and Trust

1.84%

Pension Fund

0.79%

Venture Capital

0.66%

Family Office

0.09%

Institutionelle Beteiligung

Aktualisiert: Tue, Jul 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

535

55.45M

100.20%

-990.27K

2025Q1

539

53.99M

97.68%

-2.82M

2024Q4

499

53.70M

99.42%

+875.53K

2024Q3

449

49.13M

94.16%

-1.41M

2024Q2

393

47.17M

91.61%

-2.29M

2024Q1

345

48.36M

95.04%

-4.45M

2023Q4

326

47.80M

94.81%

-4.63M

2023Q3

322

46.77M

93.30%

+2.15M

2023Q2

298

38.23M

84.44%

-1.74M

2023Q1

275

35.37M

78.88%

-3.41M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Fidelity Management & Research Company LLC

8.12M

14.67%

+55.63K

+0.69%

Mar 31, 2025

The Vanguard Group, Inc.

5.12M

9.25%

-14.09K

-0.27%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.45M

6.24%

-11.08K

-0.32%

Mar 31, 2025

AllianceBernstein L.P.

2.14M

3.87%

+391.21K

+22.32%

Mar 31, 2025

Westfield Capital Management Company, L.P.

748.56K

1.35%

+225.89K

+43.22%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.42M

2.56%

+429.46K

+43.56%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.18M

2.14%

+19.63K

+1.69%

Mar 31, 2025

T. Rowe Price Associates, Inc.

1.01M

1.83%

+334.20K

+49.20%

Mar 31, 2025

State Street Global Advisors (US)

1.19M

2.15%

-1.44K

-0.12%

Mar 31, 2025

Loomis, Sayles & Company, L.P.

1.18M

2.14%

-25.76K

-2.13%

Mar 31, 2025

Verbundene ETFs

Name

Anteil

Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

Procept Biorobotics Corp

38.320USD

Procept Biorobotics Corp

38.320

Übersicht

Unternehmen

Finanzen

Analyse